PKU is a congenital amino acid metabolic disorder. In one of the following rare variants of PKU Dihydro Biopterin synthesis is affected. The enzyme deficient is:
First, I need to recall the basics of PKU. Classic PKU is due to a deficiency in phenylalanine hydroxylase (PAH), which converts phenylalanine to tyrosine. But there are other variants. The question is about a rare variant where dihydrobiopterin (BH4) synthesis is affected. BH4 is a cofactor for PAH, so if BH4 is deficient, it can also lead to PKU-like symptoms.
The enzymes involved in BH4 synthesis include GTP cyclohydrolase I (GTPCH), 6-pyruvoyltetrahydropterin synthase (PTPS), and sepiapterin reductase (SR). These are part of the BH4 biosynthesis pathway. Deficiencies in any of these can lead to BH4 deficiency, which in turn affects PAH activity, leading to phenylalanine accumulation. However, the question specifies which enzyme is deficient in the rare variant where dihydrobiopterin synthesis is affected.
Wait, the options are not given here, but the correct answer is supposed to be one of these enzymes. Since the user hasn't provided the options, I need to infer based on standard knowledge. The most common enzyme deficiency in BH4 synthesis is GTPCH, which accounts for about 60% of BH4 deficiency cases. PTPS and SR deficiencies are rarer. So, if the question is about the enzyme involved in dihydrobiopterin synthesis, the answer is likely GTP cyclohydrolase I.
Now, for the explanation. The core concept is that PKU variants can be due to deficiencies in enzymes involved in BH4 synthesis, which is a cofactor for PAH. The correct answer would be the enzyme that catalyzes the first step in BH4 synthesis, which is GTPCH. The other options (like PTPS or SR) are also involved but less common. The wrong options might include PAH itself, which is the classic PKU enzyme, or other enzymes not related to BH4.
Clinical pearl: Remember that BH4 deficiency can present with hyperphenylalaninemia and additional symptoms like seizures or developmental delays, distinguishing it from classic PKU. Treatment includes BH4 supplementation and dietary management.
So, putting it all together, the correct enzyme is GTP cyclohydrolase I (GTPCH).
**Core Concept**
Phenylketonuria (PKU) typically results from phenylalanine hydroxylase (PAH) deficiency. However, rare variants involve defects in tetrahydrobiopterin (BH4) synthesis, a cofactor critical for PAH activity. The question targets BH4 biosynthesis pathway enzymes.
**Why the Correct Answer is Right**
The BH4 pathway begins with **GTP cyclohydrolase I (GTPCH)**, which catalyzes the first step in converting GTP to dihydrobiopterin. GTPCH deficiency accounts for ~60% of BH4 deficiency cases and is the most common rare variant of PKU. This enzyme defect disrupts BH4 synthesis, leading to impaired PAH